Phase 2 Chondrosarcoma Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
Metastatic ChondrosarcomaLocally Advanced ChondrosarcomaMetastatic Sinonasal Adenocarcinoma+7 more
National Cancer Institute (NCI)40 enrolled1 locationNCT06176989
Recruiting
Phase 2
Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Mesenchymal Chondrosarcoma
Italian Sarcoma Group16 enrolled7 locationsNCT04305548
Recruiting
Phase 2
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Soft Tissue SarcomaOsteosarcomaChondrosarcoma
Medical College of Wisconsin44 enrolled4 locationsNCT04040205
Recruiting
Phase 2
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
SarcomaCancerSolid Tumor, Adult+3 more
EpicentRx, Inc.140 enrolled6 locationsNCT04673942
Recruiting
Phase 2
A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma
Chondrosarcoma
Second Affiliated Hospital, School of Medicine, Zhejiang University70 enrolled1 locationNCT05193188